Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
口服免疫疗法治疗1-3岁花生过敏儿童的疗效和安全性（免疫耐受网络IMPACT试验）：一项随机安慰剂对照研究
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(21)02390-4
Jones, Stacie M; Kim, Edwin H; Nadeau, Kari C; Nowak-Wegrzyn, Anna; Wood, Robert A; Sampson, Hugh A; Scurlock, Amy M; Chinthrajah, Sharon; Wang, Julie; Pesek, Robert D; Sindher, Sayantani B; Kulis, Mike; Johnson, Jacqueline; Spain, Katharine; Babineau, Denise C; Chin, Hyunsook; Laurienzo-Panza, Joy; Yan, Rachel; Larson, David; Qin, Tielin; Whitehouse, Don; Sever, Michelle L; Sanda, Srinath; Plaut, Marshall; Wheatley, Lisa M; Burks, A Wesley
